{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:05:08Z","timestamp":1790629508110,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/igc.0b013e318286665b","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T08:20:12Z","timestamp":1359620412000},"page":"461-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Prognostic Factors and Clinical Outcome of Patients With Recurrent Early-Stage Epithelial Ovarian Cancer An Italian Multicenter Retrospective Study"],"prefix":"10.1016","volume":"23","author":[{"given":"Angiolo","family":"Gadducci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Cosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Zola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Sostegni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Fuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e318286665b_bb0005","first-page":"S161","article-title":"Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynaecol Obstet."},{"key":"10.1097\/IGC.0b013e318286665b_bb0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnci\/95.2.113","volume":"95","author":"Trimbos","year":"2003","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e318286665b_bb0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.critrevonc.2006.03.004","article-title":"Ovarian cancer","volume":"60","author":"Colombo","year":"2006","journal-title":"Crit Rev Oncol Hematol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0020","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/sj.bjc.6603323","article-title":"Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis","volume":"95","author":"Maggioni","year":"2006","journal-title":"Br J Cancer."},{"key":"10.1097\/IGC.0b013e318286665b_bb0025","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ygyno.2011.05.001","article-title":"Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging","volume":"122","author":"Powless","year":"2011","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ygyno.2010.12.359","article-title":"Surgical staging of early stage epithelial ovarian cancer: results from the CDC-NPCR ovarian patterns of care study","volume":"12","author":"Cress","year":"2011","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0035","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/IGC.0b013e31822127cd","article-title":"The utility of peritoneal biopsy and omentectomy in the upstaging of apparent early ovarian cancer","volume":"21","author":"Shroff","year":"2011","journal-title":"IntJ Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e318286665b_bb0040","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bpobgyn.2011.12.005","article-title":"Fertility preservation in gynaecological cancer: epithelial ovarian cancer","volume":"26","author":"Ng","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0045","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/oxfordjournals.annonc.a059355","article-title":"Adjuvant treatment for early epithelial ovarian cancer: results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P). G.I.C.O.G.: Gruppo Interregionale Collaborativo in Ginecologia Oncologica","volume":"6","author":"Bolis","year":"1995","journal-title":"Ann Oncol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/A:1008399414923","article-title":"Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument","volume":"11","author":"Trop\u00e9","year":"2000","journal-title":"Ann Oncol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/jnci\/95.2.105","volume":"95","author":"Trimbos","year":"2003","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e318286665b_bb0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jnci\/95.2.125","article-title":"International Collaborative Ovarian Neoplasm (ICON). International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer","volume":"95","author":"Colombo","year":"2003","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e318286665b_bb0065","first-page":"CD004706","article-title":"Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer","author":"Winter-Roach","year":"2009","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1097\/IGC.0b013e318286665b_bb0070","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/jnci\/djq149","article-title":"Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial","volume":"102","author":"Trimbos","year":"2010","journal-title":"J Natl Cancer Inst."},{"key":"10.1097\/IGC.0b013e318286665b_bb0075","first-page":"432","article-title":"Gynecologic Oncology Group","volume":"102","author":"Bell","year":"2006","journal-title":"Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygyno.2009.10.073","article-title":"The potential benef it of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study","volume":"116","author":"Chan","year":"2010","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0085","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1471-0528.2010.02635.x","article-title":"Platinum-based adjuvant chemotherapy for early-stage epithelial ovarian cancer: single or combination chemotherapy?","volume":"117","author":"Adams","year":"2010","journal-title":"BJOG."},{"key":"10.1097\/IGC.0b013e318286665b_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2011.06.033","article-title":"Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin\/paclitaxel chemotherapy: a single institution experience","volume":"123","author":"Bamias","year":"2011","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0095","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1525-1438.1997.09742.x","article-title":"Analysis of failures in patients with stage I ovarian cancer: an Italian multicenter study","volume":"7","author":"Gadducci","year":"1997","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e318286665b_bb0100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(00)03590-X","article-title":"Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma","volume":"357","author":"Vergote","year":"2001","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e318286665b_bb0105","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/cncr.23390","article-title":"Tian C, Monk BJ, et al, Gynecologic Oncology Group. Prognostic factors for high-risk early stage epithelial ovarian cancer: a Gynecologic Oncology Group study","volume":"112","author":"Chan","year":"2008","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e318286665b_bb0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ygyno.2011.02.038","article-title":"Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery","volume":"122","author":"Paulsen","year":"2011","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2009.10.074","article-title":"Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study","volume":"116","author":"Chan","year":"2010","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0120","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1200\/JCO.2003.06.119","article-title":"Can patients with relapsed, previously untreated, stage I epithelial ovarian cancer be successfully treated with salvage therapy?","volume":"21","author":"Kolomainen","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0125","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.critrevonc.2005.03.003","article-title":"Consolidation and maintenance treatments for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy: a review of the literature","volume":"55","author":"Gadducci","year":"2005","journal-title":"Crit Rev Oncol Hematol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0135","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1200\/JCO.1994.12.10.2066","article-title":"Long-term follow-up of the first randomized study of cisplatin versus carboplatin for advanced epithelial ovarian cancer","volume":"12","author":"Taylor","year":"1994","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0140","first-page":"2426","article-title":"Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer","volume":"16","author":"Gore","year":"1998","journal-title":"London Gynaecol Oncol Group J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318286665b_bb0145","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1056\/NEJMoa041125","article-title":"Secondary surgical cytoreduction for advanced ovarian carcinoma","volume":"351","author":"Rose","year":"2004","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0b013e318286665b_bb0150","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","article-title":"Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma","volume":"106","author":"Chi","year":"2006","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e318286665b_bb0155","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncr.22447","article-title":"Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome","volume":"109","author":"Salani","year":"2007","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e318286665b_bb0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/IGC.0b013e31820aaafd","article-title":"Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO","volume":"21","author":"Harter","year":"2011","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e318286665b_bb0165","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","article-title":"Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial","volume":"13","author":"Harter","year":"2006","journal-title":"Ann Surg Oncol."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24018930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24018930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0b013e318286665b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:24:16Z","timestamp":1753223056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24018930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1048891X24018930"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e318286665b","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Factors and Clinical Outcome of Patients With Recurrent Early-Stage Epithelial Ovarian Cancer An Italian Multicenter Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e318286665b","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2013 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}